(Total Views: 463)
Posted On: 04/15/2020 9:18:25 AM
Post# of 151768
Thanks TG. One thing that I cannot understand is why the FDA required a Placebo Arm in a Trial of Severely Ill patients with historically high mortality rates. Maybe I'm wrong, but I would think the Control/Placebo Comparator would be the general population of severely ill patients who have not been treated with Leronlimab or whatever medicine was the subject of the study.
Further, if I were the patient's Doctor, I would request EIND before enrolling my patient in a Trial which gave them just a 66% chance of actually receiving the medicine I believed could help them, perhaps even save their lives.
Where am I going wrong?
Further, if I were the patient's Doctor, I would request EIND before enrolling my patient in a Trial which gave them just a 66% chance of actually receiving the medicine I believed could help them, perhaps even save their lives.
Where am I going wrong?
(1)
(0)Scroll down for more posts ▼
